India's first dengue vaccine approved India's drug regulatory authority has approved the Kydenga vaccine against dengue for use. The dengue vaccine has been approved in India. The vaccine named Kydenga, developed by a Japanese company against the dengue virus, has been approved for use in India. Developed by Japanese pharmaceutical company Takeda Pharmaceuticals , this vaccine has been approved by India's drug regulatory authority Central Drug Standards and Organization (CDACO). The Kydenga vaccine is said to provide protection against all four types of dengue virus serotypes 1, 2, 3 and 4 . Like the COVID-19 vaccine , it requires two doses. The second dose should be given three months after the first dose. This vaccine, which can be given to people aged 4 to 60 years, can also be given to those who have not had dengue. This vaccine, which is currently being produced in India, currently costs between Rs 6,000 and Rs 12,000 per dose . The price is expected to come down in ...
Morning walk and heart in winter To walk or not to walk in the morning this winter? Don't tell me.' A friend of the health media got a call. "Why?" I asked naturally. "Let's write something about what to do in the cold for those who have or may have heart disease." Oh what a great idea. We were mostly discussing other causes of heart disease. This particular winter month is important for more information. What a good thing you said. In winter, too much cold affects the heart. It is better to give information about this,' I said. Dr. Rajendra Koju "That's why I asked, how many people may be suffering without knowing about it," came the frank words of a journalist friend. As soon as he hung up the phone, something from 17 years ago came to his mind. One cold winter afternoon, I was looking after the patient in the outdoor department after midterm. Around 4 o'clock when it was almost over, a couple of familiar professors came to me. ...